Blog
Can NIKE Reignite Growth Amid Ongoing Wholesale Reset Pressures?
NIKE Inc. NKE is at a pivotal juncture as it works through a broad reset of its wholesale and marketplace strategy. After years of prioritizing direct-to-consumer expansion, the company is
Powell Industries Q1 Earnings Surpass Estimates, Increase Y/Y
Powell Industries, Inc.’s POWL first-quarter fiscal 2026 (ended December 2025) adjusted earnings of $3.40 per share surpassed the Zacks Consensus Estimate of $2.85. The bottom line increased 19%
Emerson Q1 Earnings Top Estimates, Intelligent Devices Sales Rise
Emerson Electric Co. EMR reported first-quarter fiscal 2026 (ended Dec. 31, 2025) adjusted earnings of $1.46 per share, which surpassed the Zacks Consensus Estimate of $1.41. The bottom line
Johnson Controls Q1 Earnings & Revenues Top Estimates, Increase Y/Y
Johnson Controls International plc JCI reported first-quarter fiscal 2026 (ended December 2025) adjusted earnings of 89 cents per share, which beat the Zacks Consensus Estimate of 84 cents. The
Carlisle Q4 Earnings Beat Estimates, Organic Revenues Decline Y/Y
Carlisle Companies Incorporated CSL reported fourth-quarter 2025 adjusted earnings of $3.90 per share, which beat the Zacks Consensus Estimate of $3.60. However, the bottom line decreased 13% year
IDEX Q4 Earnings Surpass Estimates, Sales Increase Year Over Year
IDEX Corporation’s IEX fourth-quarter 2025 adjusted earnings of $2.10 per share surpassed the Zacks Consensus Estimate of $2.04. The bottom line increased 3% on a year-over-year basis.In 2025, the
Stanley Black's Q4 Earnings Beat Estimates, Revenues Miss
Stanley Black & Decker, Inc. SWK reported fourth-quarter 2025 adjusted earnings of $1.41 per share, which beat the Zacks Consensus Estimate of $1.27. However, the bottom line decreased 5.4% year
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test
Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte algorithmic blood test designed to aid in the evaluation of patients with
T. Rowe Price Stock Down 6.4% as Q4 Earnings Miss, Expenses Rise Y/Y
T. Rowe Price Group, Inc.’s TROW fourth-quarter 2025 adjusted earnings per share (EPS) of $2.44 missed the Zacks Consensus Estimate of $2.47. Nevertheless, the bottom line increased 15.1% year over
Here's Why You Should Add Masimo Stock to Your Portfolio Now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism
Bull Of The Day: KULR Technology Group (KULR)
KULR Technology Group (KULR) is a Zacks Rank #2 (Buy) that has a F for Value and an F for Growth. This company develops thermal management technologies for electronics, batteries and other
3 Reasons Growth Investors Will Love Aramark (ARMK)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth
3 Reasons Why Growth Investors Shouldn't Overlook Lam Research (LRCX)
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great
3 Reasons Why Subsea 7 (SUBCY) Is a Great Growth Stock
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock
KBR Wins $149M Air Force Contract, Boosts Defense Digital Franchise
KBR, Inc. KBR recently won a $149 million cost-plus-fixed-fee contract under the Acquisition, Data, Engineering, Digital, Decision Integration and Software (ADEDDIS) program. This contract
Should Celestica Be in Your Portfolio Post Strong Q4 Earnings?
Celestica, Inc. CLS recorded strong fourth-quarter 2025 results with adjusted earnings and revenues beating the respective Zacks Consensus Estimate. Top-line expansion year over year is backed by
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y
Shares of Utah Medical Products, Inc. UTMD have gained 2% since the company reported its fourth-quarter and full-year 2025 earnings. This outpaced the S&P 500 index’s modest 0.2% growth over the
Is a Beat in Store for Cincinnati Financial This Earnings Season?
Cincinnati Financial Corporation CINF is expected to register an improvement in its top line but a decline in its bottom line when it reports fourth-quarter 2025 results on Feb. 9, after the
Ryanair's Traffic Numbers for January 2026 Improve Year Over Year
Ryanair Holdings RYAAY, a European carrier, reported solid traffic numbers for January 2026, driven by upbeat air-travel demand.
The number of passengers transported on Ryanair flights was 12.7
AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View
AbbVie Inc. ABBV reported fourth-quarter 2025 adjusted EPS of $2.71, which beat the Zacks Consensus Estimate of $2.66. The reported figure also exceeded the company’s guidance of $2.61-$2.65 issued
Visa-UnionPay Link-Up: A Turning Point in Cross-Border Money Flow?
Visa Inc. V is ramping up its efforts in global money movement through a partnership with UnionPay International (“UPI”). This collaboration aimed at expanding the reach of Visa Direct in the
Surging Earnings Estimates Signal Upside for Avidbank Holdings (AVBH) Stock
Avidbank Holdings Inc. (AVBH) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might
Why Western Digital (WDC) Might be Well Poised for a Surge
Western Digital (WDC) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with
Surging Earnings Estimates Signal Upside for Ivanhoe Mines Ltd. (IVPAF) Stock
Investors might want to bet on Ivanhoe Mines Ltd. (IVPAF), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price
Why Merchants Bancorp (MBIN) Might be Well Poised for a Surge
Merchants Bancorp (MBIN) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue


